See also this year's filing and all EDGAR filings for this company.
PDF Report 0001430306_2021_Tonix_Pharmaceuticals_Holding_Corp.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001430306')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001430306, Tonix Pharmaceuticals Holding Corp.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 87,989,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 120,000 |
| 2 | PropertyPlantAndEquipmentNet | 8,571,000 |
| 3 | remainder_Assets | 1,503,000 |
| 4 | LiabilitiesCurrent | 9,819,000 |
| 5 | LiabilitiesNoncurrent | 716,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 14,354,000 |
| 9 | ResearchAndDevelopmentExpense | 36,157,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 48,000 |
| 13 | remainder_ComprehensiveNetIncome | -16,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 98,183,000 |
| 1 | Liabilities | 10,535,000 |
| 2 | Expenses | 50,511,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 87,648,000 |
| 5 | NetIncome | -50,463,000 |
| 6 | ComprehensiveNetIncome | -50,471,000 |
| 7 | BaseVar | 79,646,500 |
| 8 | EconomicCapitalRatio | 1.84 |
Edgar->Model Mapping
Feature Distribution
Change over Time
